Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
9 hedge funds and large institutions have $38.5K invested in Petros Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0.03% less ownership
Funds ownership: 0.07% → 0.04% (-0.03%)
18% less funds holding
Funds holding: 11 → 9 (-2)
35% less capital invested
Capital invested by funds: $59.2K → $38.5K (-$20.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$11.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.16K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$441 |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$41 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $14.3K | -$441 | -54 | -4% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $12.5K | – | – | – |
|
3
BlackRock
New York
| $6.35K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.12K | -$10.2K | -1,249 | -71% |
|
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $79 | -$41 | -5 | -38% |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $78 | – | – | – |
|
7
Group One Trading
Chicago,
Illinois
| $31 | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $29 | – | – | – |
|
9
Morgan Stanley
New York
| $8 | – | – | – |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$11.5K | -1,291 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$1.16K | -130 | Closed |
|
PTPI Hedge Fund Activity: Q4 2024 in Review
9 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q4 2024, worth a combined $38.5K — down 35% from $59.2K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PTPI and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Two Sigma Securities, exiting entirely with an estimated $11.5K sold.
- 9 institutional investors held Petros Pharmaceuticals (PTPI) as of Q4 2024, down from 11 in Q3 2024.
- Funds reported $38.5K of Petros Pharmaceuticals stock for Q4 2024, down 35% quarter-over-quarter.
- 0 funds opened new Petros Pharmaceuticals positions in Q4 2024 and 2 closed out, a net change of -2 holders.
- The largest Petros Pharmaceuticals seller in Q4 2024 was Two Sigma Securities, an estimated $11.5K sold.
Based on aggregated 13F filings for Q4 2024.